132 related articles for article (PubMed ID: 19839876)
21. Graves' orbitopathy: a multidisciplinary approach.
Limone PP; Mellano M; Ruo Redda MG; Macera A; Ferrero V; Sellari Franceschini S; Deandrea M
Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):157-171. PubMed ID: 33634673
[TBL] [Abstract][Full Text] [Related]
22. [Management of Graves' orbitopathy: evidence-based recommendations].
Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
[TBL] [Abstract][Full Text] [Related]
23. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.
Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS
Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772
[TBL] [Abstract][Full Text] [Related]
24. [Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement].
Bednarczuk T; Bar-Andziak E; Hubalewska-Dydejczyk A; Waligórska A; Górska M; Myśliwiec J; Jarzab B; Karczmarzyk R; Zawadzka A; Garmol D; Kecik D; Królicki L; Plazińska MT; Krzeski A; Krzyzanowska-Swiniarska B; Lewiński A; Milewicz A; Daroszewski J; Placzkiewicz-Jankowska E; Pilarska K; Skórski M; Wiechno W; Sowiński J; Syrenicz A; Szafilk J; Wanyura H; Zgliczński W; Jastrzebska H; Nauman J
Endokrynol Pol; 2009; 60(4):312-30. PubMed ID: 19753546
[No Abstract] [Full Text] [Related]
25. Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions.
Tanda ML; Lai A; Bartalena L
Clin Endocrinol (Oxf); 2008 Dec; 69(6):845-7. PubMed ID: 18785990
[No Abstract] [Full Text] [Related]
26. Management of patients with Graves' orbitopathy: initial assessment, management outside specialized centres and referral pathways.
Orgiazzi J
Clin Endocrinol (Oxf); 2016 May; 84(5):662-3. PubMed ID: 26866718
[No Abstract] [Full Text] [Related]
27. Diagnosis and management of thyroid orbitopathy.
Rose JG; Burkat CN; Boxrud CA
Otolaryngol Clin North Am; 2005 Oct; 38(5):1043-74. PubMed ID: 16214573
[No Abstract] [Full Text] [Related]
28. [Graves' Orbitopathy].
Eckstein A; Esser J; Mattheis S; Berchner-Pfannschmidt U
Klin Monbl Augenheilkd; 2016 Dec; 233(12):1385-1407. PubMed ID: 27871109
[No Abstract] [Full Text] [Related]
29. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.
Bartalena L; Baldeschi L; Dickinson A; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits M; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas GE; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM;
Eur J Endocrinol; 2008 Mar; 158(3):273-85. PubMed ID: 18299459
[No Abstract] [Full Text] [Related]
30. [The expected and unexpected: key points in the 2021 European Group on Graves' Orbitopathy clinical practice guidelines for the management of Graves' orbitopathy].
Pan Q; Lyu ZH; Guan HX
Zhonghua Nei Ke Za Zhi; 2022 Jan; 61(1):8-11. PubMed ID: 34979768
[TBL] [Abstract][Full Text] [Related]
31. Critical issues on Graves' ophthalmopathy.
Rocchi R
MLO Med Lab Obs; 2006 May; 38(5):10-2, 14-5; quiz 16-7. PubMed ID: 16761864
[No Abstract] [Full Text] [Related]
32. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy.
Bartalena L; Baldeschi L; Dickinson AJ; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits MP; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas G; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM
Thyroid; 2008 Mar; 18(3):333-46. PubMed ID: 18341379
[No Abstract] [Full Text] [Related]
33. Graves upper eyelid retraction.
Cruz AA; Ribeiro SF; Garcia DM; Akaishi PM; Pinto CT
Surv Ophthalmol; 2013; 58(1):63-76. PubMed ID: 23217588
[TBL] [Abstract][Full Text] [Related]
34. A symposium on thyroid-associated ophthalmopathy, also known as Graves' orbitopathy at the Jules Stein Eye Institute at the University of California, Los Angeles.
Douglas RS; Goldberg RA; Smith TJ
Thyroid; 2008 Sep; 18(9):931. PubMed ID: 18788916
[No Abstract] [Full Text] [Related]
35. A treatment strategy for Graves' orbitopathy.
Marcocci C; Pinchera A; Marinò M
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970
[TBL] [Abstract][Full Text] [Related]
36. [Current management of endocrine orbitopathy].
Ponto KA; Kahaly GJ
Med Klin (Munich); 2008 Oct; 103(10):717-30; quiz 729-30. PubMed ID: 18936897
[No Abstract] [Full Text] [Related]
37. [Pathogenetic, clinical and therapeutical features of ophthalmologic involvement in Basedow's disease].
Verraz R
Arch Sci Med (Torino); 1969 Sep; 126(9):699-704. PubMed ID: 17340828
[TBL] [Abstract][Full Text] [Related]
38. Graves' Opthalmopathy.
Rosenberg Bezalel S; Elbirt D; Leiba H; Sthoeger ZM
Isr Med Assoc J; 2017 Mar; 19(3):188-192. PubMed ID: 28457100
[No Abstract] [Full Text] [Related]
39. [Update on endocrine orbitopathy].
Ponto KA; Kahaly GJ; Pitz S
Klin Monbl Augenheilkd; 2009 Feb; 226(2):R13-28; quiz R29-31. PubMed ID: 19206039
[No Abstract] [Full Text] [Related]
40. [Emphasizing the fundamental and clinical research on thyroid-associated ophthalmopathy].
Wu ZY; Song GX
Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):769-71. PubMed ID: 16191339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
